Crossmark

Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s10334-018-0687-7

Published Online: 2018-05-08

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khantasup, Kannika

Saiviroonporn, Pairash

Jarussophon, Suwatchai

Chantima, Warangkana

Dharakul, Tararaj https://orcid.org/0000-0002-5602-0778
Funding

Funding for this research was provided by:

Siriraj Research Development Fund, Faculty of Medicine Siriraj Hospital, Mahidol University

Center of Excellence Network Program by the Faculty of Medicine Siriraj Hospital, Mahidol University and the National Nanotechnology Center (NANOTEC), Ministry of Science and Technology, Thailand
License Information

Text and Data Mining valid from 2018-05-08
More Information

Article History

Received: 6 December 2017

Revised: 29 March 2018

Accepted: 25 April 2018

First Online: 8 May 2018

Compliance with ethical standards

:

: The authors declare that they have no conflicts of interest. For this type of study, formal consent is not required.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study formal consent is not required.